Brief: Brickell Biotech Announces Pricing Of $15.0 Mln Underwritten Public Offering
Oct 22 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH ANNOUNCES PRICING OF $15.0 MILLION
UNDERWRITTEN
PUBLIC OFFERING
* ANNOUNCED PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF
20.8
MILLION SHARES OF COMMON STOCK
* SHARES AND WARRANTS ARE BEING SOLD AT A COMBINED OFFERING
PRICE
OF $0.72
Source text for Eikon: ID:nGNX7DXtZ
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx